Intralipid recalls
Intralipid products have been recalled 3 times, most recently on 15 Jun 2022. The recalling company is usually Mckesson Medical-Surgical Inc. Corporate Office. The most common reason is manufacturing (cgmp) deviations.
Total recalls3since 2017
Last 12 months0reported
Class I133% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 2 67%Class III 0 0%
Why intralipid is recalled
Companies
By year
All intralipid recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Intralipid (I.V recalled by Mckesson Medical-SurgicalIntralipid | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Intralipid (I.V recalled by Mckesson Medical-SurgicalIntralipid | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Intralipid 20%, A 20% I.V recalled by Baxter HealthcareIntralipid | Baxter Healthcare | Temperature Abuse | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.